Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update
Date
2020Author
Lundberg, Sigrid
Roberts, Ian S. D.
Cattran, Daniel
Barratt, Jonathan
Del Vecchio, Lucia
Locatelli, Francesco
Perkowska-Ptasinska, Agnieszka
Durlik, Magdalena
Moggia, Elisabetta
Ballarin, Jose C.
Wetzels, Jack F. M.
Goumenos, Dimitris
Papasotiriou, Marios
Galesic, Kresimir
Toric, Luka
Papagianni, Aikaterini
Stangou, Maria
Benozzi, Luisa
Cusinato, Stefano
Berg, Ulla
TOPALOĞLU, REZAN
Maggio, Milena
Ots-Rosenberg, Mai
D'Amico, Marco
Geddes, Colin
Balafa, Olga
Quaglia, Marco
Cravero, Raffaella
Cirami, Calogero Lino
Fellstrom, Bengt
Floege, Juergen
Egido, Jesus
Mallamaci, Francesca
Zoccali, Carmine
Pierucci, Alessandro
Caliskan, Yasar
Coppo, Rosanna
D'Arrigo, Graziella
Tripepi, Giovanni
Bellur, Shubha
Cook, Terence H.
Feehally, John
Tesar, Vladimir
Maixnerova, Dita
Peruzzi, Licia
Amore, Alessandro
Russo, Maria Luisa
Di Palma, Anna Maria
Gesualdo, Loreto
Emma, Francesco
Rollino, Cristiana
Praga, Manuel
Biancone, Luigi
Pani, Antonello
Feriozzi, Sandro
Polci, Rosaria
Metadata
Show full item recordAbstract
Background. It is unknown whether renal pathology lesions in immunoglobulin A nephropathy (IgAN) correlate with renal outcomes over decades of follow-up.
Collections
- Makale [92796]